Clinical insight creates the venture, but evidence, reimbursement and distribution determine whether it survives contact with the health system.
When inference is the product, medical device economics shift from units shipped to judgments delivered, verified, reimbursed and maintained in clinical context.
Clinician-founders win by aligning evidence, reimbursement and distribution in the order dictated by buying risk, not by clinical enthusiasm alone.
